<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Chemotherapy":3,
"Hypothyroidism":3,
"Malignancy":4,
"Optimal therapy":1,
"Review":2,
"BRAF kinase":1,
"Histiocytosis":1,
"Leukemia":2,
"V600E mutation":1,
"radioiodine therapy":3,
"salivary gland dysfunction":1,
"sialadenitis":1,
"thyroid cancer":47,
"xerostomia":2,
"hyperglycemia":1,
"hyperinsulinemia":2,
"insulin resistance":1,
"papillary thyroid cancer":12,
"esophageal invasion":1,
"functional outcomes":1,
"laryngeal invasion":1,
"tracheal invasion":1,
"Cell block":1,
"fine needle aspiration cytology":3,
"immunohistochemistry":19,
"intrathyroidal metastasis":1,
"BRAFV600E mutation":3,
"Hashimoto's thyroiditis":1,
"aggressiveness":1,
"stage":1,
"airway obstruction":1,
"anaplastic thyroid cancer":6,
"stridor":1,
"tracheotomy":1,
"PTTG1IP":1,
"TP53":2,
"colon":1,
"colorectal tumorigenesis":1,
"oncogene":1,
"Apoptosis":5,
"Cell cycle":2,
"Medullary thyroid cancer":2,
"cAMP analogs":1,
"cAMP-dependent protein kinase A (PKA) pathway":1,
"Endoscopic thyroidectomy":1,
"Minimally invasive surgery":1,
"Modified facelift approach":1,
"Remote access":1,
"Retroauricular approach":1,
"mandibular tumors":1,
"maxillary tumors":1,
"odontogenic fibromyxoma":1,
"odontogenic myxoma":1,
"pediatric tumors":2,
"Fordyce granules":1,
"Muir-Torre syndrome":1,
"intraoral":1,
"oral metastases":1,
"sebaceous carcinoma":1,
"Core-needle biopsy":1,
"Fine-needle aspiration":7,
"Thyroid carcinoma":10,
"Thyroid nodule":9,
"Ultrasound":7,
"Ectopic thyroid":1,
"Lingual thyroid":1,
"Lingual thyroid carcinoma":1,
"Incomplete response":1,
"Predictors":1,
"Minimally invasive follicular carcinoma":1,
"RAI":1,
"Surgery":7,
"Thyroid":27,
"Colorectal neoplasms":1,
"Mediator complex subunit 1":1,
"PPARγ":1,
"Carcinoma tiroideo":1,
"End-stage renal disease":2,
"Haemodialysis":1,
"Hemodiálisis":1,
"Insuficiencia renal terminal":1,
"Kidney transplantation":1,
"Radioiodine":5,
"Radioyodo":1,
"Trasplante renal":1,
"ImageStreamX imaging flow cytometry":1,
"circulating tumour cells":1,
"hepatocellular carcinoma":2,
"oesophageal adenocarcinoma":1,
"ovarian cancer":3,
"EPIC":1,
"differentiated thyroid carcinomas":1,
"glycemic index":1,
"macronutrients":1,
"total energy":1,
"2-Methoxyestradiol":1,
"Cabozantinib":1,
"Hypoxia-inducible factor":1,
"Medullary thyroid carcinoma":8,
"Signal transduction pathway":1,
"N-cadherin":1,
"Papillary thyroid carcinoma":30,
"Snail":2,
"BRAF":6,
"CD117":1,
"Immunocytochemistry":2,
"CDC20":1,
"Carcinomas":1,
"Normal/non-neoplastic tissues":1,
"hemodialysis":1,
"Genetic phenotype":1,
"Lung adenocarcinoma":1,
"Mucin-producing adenocarcinoma":1,
"Pathological subtype":1,
"Survival":6,
"Cancer":12,
"Germline mutation":2,
"RET proto-oncogene":1,
"Mutation":4,
"RAS":2,
"RET/PTC":3,
"Forkhead box P3":1,
"Sodium iodine symporter":1,
"TGF-β1":1,
"Single-nucleotide polymorphism":1,
"X-ray repair cross-complementing group 3":1,
"DICER1":1,
"MiRNA":2,
"Sarcoma":1,
"Sertoli-Leydig cell tumor":1,
"Antisense-miR-21":1,
"Cancer stem cell":1,
"Differentiation":1,
"Biopsy, fine-needle":2,
"Carcinoma, papillary":1,
"Carcinoma, papillary, follicular":1,
"Thyroid gland":6,
"Ultrasonography":8,
"Meta-analysis":5,
"Systemic lupus erythematosus":1,
"Cancer incidence rate":1,
"Nuclear power plants":2,
"14q32 deletion":1,
"DIO3":1,
"DLK1":1,
"Temple syndrome":1,
"YY1":1,
"Breast cancer":8,
"CtBP1":1,
"EMT":2,
"Metastasis":18,
"miR-137":1,
"DNA mutational analysis":1,
"fine-needle aspiration biopsy":4,
"high-throughput nucleotide sequencing":1,
"microarray analysis":1,
"molecular diagnostic techniques":1,
"thyroid neoplasms":13,
"PAX8":2,
"PNET":1,
"Renal PNET":1,
"multimorbidity":1,
"restless legs syndrome":1,
"risk alleles":1,
"Diagnosis":8,
"Elastography":4,
"Inter-observer variability":1,
"cytology":3,
"fine needle aspiration":7,
"microcalcifications":1,
"GPCR":1,
"adrenal cortex":1,
"cyclic AMP":1,
"gonad":1,
"neonate":1,
"parathyroid":3,
"proliferation":4,
"signal transduction":1,
"FTO":1,
"IVSA1-27777C&gt":1,
"A":1,
"Polymorphism":3,
"rs8050136":1,
"adolescents and young adults":1,
"late effects":1,
"pediatric oncology":2,
"radiation":3,
"second malignant neoplasms":1,
"fibroblast growth factor 19":1,
"motility":1,
"small interfering RNA":1,
"Acute":2,
"Myeloid":1,
"Radiation-induced":1,
"Radioisotopes":2,
"Cancer biomarker":1,
"Cancer invasion":1,
"Extracellular vesicles":1,
"Integrin-FAK signaling":1,
"Alpha lipoic acid":1,
"Epithelial–mesenchymal transition":1,
"Transforming growth factor beta":1,
"FNA":1,
"calcitonin":2,
"washout":1,
"TROP-2":1,
"124I PET/CT":1,
"131I SPECT/CT":1,
"detectability":1,
"phantom":1,
"Cervical metastasis":1,
"Node metastatic pattern":1,
"Aneuploidy":1,
"Bisphenol A":1,
"Endocrine disruptors":1,
"Environment":1,
"Estrogens":1,
"Neoplasm":3,
"Steroids":1,
"Systematic review":2,
"postoperative nonstimulated thyroglobulin":1,
"recurrence":4,
"bilaterality":1,
"lymph node metastasis":2,
"multifocality":1,
"Atypia of undetermined significance":2,
"Bethesda III category":1,
"Factors to triage to thyroid surgery":1,
"Predictive factors for thyroid malignancy":1,
"Selection of nodules for thyroid surgery":1,
"JAK2-STAT3 signaling":1,
"Pten-deficiency":1,
"STAT3 inhibitor":1,
"obesity":3,
"preclinical mouse model":1,
"thyroid hormone receptor β mutant":1,
"BRAF mutation":3,
"central lymph node metastasis":1,
"chronic lymphocytic thyroiditis":1,
"extrathyroidal extension":4,
"Head and neck cancer":1,
"Head and neck surgery":1,
"Neck dissection":2,
"Nodal yield":1,
"Robotic surgery":1,
"ALK":1,
"Crizotinib":1,
"Lung cancer":6,
"Squamous cell carcinoma":3,
"Afirma":2,
"Bethesda classification":1,
"Genetic testing":1,
"Molecular markers":1,
"Thyroid nodules":6,
"Central neck lymph node dissection":1,
"Lymph node dissection":2,
"Lymph node metastases":3,
"Recurrent thyroid cancer":1,
"I(131)":1,
"Radioactive iodine":1,
"TSH suppression":2,
"Adrenal":1,
"Hemoperitoneum":1,
"Multiple endocrine neoplasia":3,
"Pheochromocytoma":2,
"anticoagulation":1,
"head and neck ultrasound":2,
"thyroid fine-needle aspiration":1,
"Papillary thyroid carcinoma (PTC)":1,
"Right paraesophageal lymph node (RPELN)":1,
"chemokine":1,
"innate immunity":1,
"tumor vasculature":1,
"tumor-associated macrophages":1,
"virotherapy":1,
"outcome":1,
"prognosis":7,
"risk stratification":1,
"Akt1":1,
"Invasion":5,
"miR-409-3p":1,
"Hypercalcaemia":1,
"Parathyroid hormone":1,
"Parathyroidectomy":2,
"Primary hyperparathyroidism":2,
"Thyroid disease":2,
"KSR1":1,
"chemosensitivity":1,
"colorectal cancer":2,
"miR-497":1,
"tumorigenesis":1,
"Iodine radioisotopes":1,
"Molecular targeted therapy":1,
"Survival analysis":1,
"Thyroglobulin":8,
"Thyroid neoplasm":2,
"Advanced":1,
"Differentiated":1,
"Medullary":1,
"Multikinase":1,
"Refractory":1,
"carcinoma of unknown primary (CUP)":1,
"circulating tumor cells (CTCs)":1,
"immunofluorescence":1,
"Nrf2":2,
"ORP150":1,
"proteasome inhibitor":1,
"BRD4":1,
"C-MYC":1,
"JQ1":1,
"NIS":1,
"assays":1,
"biomarker":5,
"differentiated thyroid cancers":1,
"Colorectal carcinoma":1,
"Melanoma":4,
"NRAS":1,
"nuclear corepressor 1":1,
"thyroid hormone receptor":1,
"transcription":1,
"tumor growth":1,
"Hip":1,
"Metal-on-metal":1,
"cobalt":1,
"tociity":1,
"Diffusion-weighted imaging":2,
"benign thyroid diseases":1,
"changes of radioiodine therapy":1,
"jóindulatú pajzsmirigybetegségek":1,
"pajzsmirigyrák":1,
"radiojódterápia változásai":1,
"atypia of undetermined significance (AUS)":1,
"quality":1,
"repeat fine-needle aspiration (FNA)":1,
"Metabolic syndrome":2,
"Head and neck neoplasms":2,
"Microbiology":1,
"Surgical site infection":1,
"Diet":1,
"Radioactivity":1,
"Radionuclide":1,
"Risk Assessment":1,
"Akt/PKB kinases":1,
"adrenocortical carcinoma":1,
"gastroenteropancreatic neuroendocrine tumors":1,
"neuroblastoma":2,
"parathyroid tumors":1,
"phaeochromocytoma":1,
"pituitary tumors":1,
"thyroid tumors":1,
"DNA methylation":1,
"Discordant monozygotic twins":1,
"Epigenetics":1,
"Twin study":1,
"Follicular Thyroid Carcinoma":2,
"Free Tissue Flaps":1,
"Mediastinum":1,
"immunomarker":1,
"thyroid lesions":2,
"Maternal mortality":1,
"Neoplasms":1,
"Pregnancy":2,
"Pregnancy outcome":1,
"differentially-expressed gene":1,
"modules":1,
"chromosome rearrangement":1,
"chronic myelomonocytic leukemia":1,
"gene fusion":1,
"platelet-derived growth factor receptor β":1,
"Differentiated thyroid cancer":6,
"Follicular thyroid cancer":1,
"Spine":1,
"Vertebrae":1,
"clinicopathogical":1,
"primary lung intestinal adenocarcinoma":1,
"Radionuclide imaging":1,
"131I":2,
"brain":1,
"hemimegalencephaly":1,
"renal":1,
"single photon emission computed tomography-computed tomography":1,
"thyroid cancerhemihypoperfusion":1,
"Hypofractionated radiotherapy":1,
"intensity modulated radiotherapy":1,
"melanotic medullary carcinoma thyroid":1,
"tumor thrombus":1,
"Spain":1,
"adolescents":1,
"childhood":1,
"incidence":2,
"population-based study":1,
"solid tumour":1,
"Eosinophilia":1,
"sclerosing mucoepidermoid carcinoma":1,
"Papillary carcinoma":5,
"Sistrunk operation":1,
"thyroglossal duct":1,
"AXIN2":1,
"Papillary":3,
"Single Nucleotide":1,
"Dual malignancies":1,
"metachronous malignancy":1,
"multiple primary cancers":1,
"synchronous malignancy":1,
"fibrous dysplasia":1,
"monostotic":1,
"spinal cord compression":1,
"thoracic vertebra":1,
"antioxidants":1,
"malondialdehyde":2,
"protein carbonyl":1,
"superoxide dismutase":1,
"Good outcome":1,
"Ibadan":1,
"Nigeria":1,
"Retrosternal goitre":1,
"Sternotomy":1,
"Total thyroidectomy":1,
"Bamako":1,
"CHU du Point G":1,
"Point G University Hospital":1,
"chirurgie":1,
"goiter":3,
"goitre":1,
"cardiovascular risk":1,
"differentiated thyroid carcinoma":8,
"hsCRP":1,
"myocardial perfusion":1,
"thyroid hormone withdrawal":1,
"occult carcinoma":1,
"papillary micro-carcinoma":1,
"clear cell renal carcinoma":1,
"thyroid secondary neoplasm":1,
"16p11 2":1,
"9q22":1,
"Extraskeletal myxoid chondrosarcoma":1,
"FUS":1,
"NR4A3":1,
"complication":2,
"hematoma":1,
"risk factor":3,
"thyroid surgery":1,
"anaplastic thyroid carcinoma":4,
"oncolytic virus":1,
"vaccinia":1,
"viral therapy":1,
"diagnostic accuracy":1,
"thyroid reporting and data system":1,
"18F-fluorodeoxyglucose (FDG)-positron emission tomography (PET)":1,
"negative radioiodine whole-body scan":1,
"chondrosarcoma":1,
"cricoid reconstruction":1,
"laryngotracheal reconstruction":1,
"laryngotracheal stenosis":1,
"subglottic stenosis":1,
"temporoparietal fascial flap":1,
"tracheal reconstruction":1,
"vascularized composite autograft (VCAG)":1,
"cervical":1,
"frozen sections":1,
"lymph node":2,
"Anterior commissure":1,
"Laryngeal cancer":2,
"Thyroid cartilage":2,
"breast carcinoma":1,
"invasive micropapillary carcinoma":1,
"arterial stiffness":1,
"central blood pressure":1,
"global longitudinal strain":1,
"hypertension":1,
"pulse wave velocity":1,
"vascular endothelial growth factor receptor":1,
"Castleman disease":1,
"Positron emission tomography":4,
"Carbon nanoparticles":1,
"Reoperation":1,
"131I-SPECT/CT":1,
"Stimulated serum thyroglobulin":1,
"triple negative breast cancer":1,
"Genetics":2,
"Mouse modeling":1,
"Pre-clinical models":1,
"Hürthle cell tumors":1,
"Immune-histochemical markers":1,
"Thyroid malignancy markers":1,
"Akt":2,
"HDAC inhibitor":1,
"SNX5422":1,
"Synergism":1,
"Diabetes insipidus":1,
"Metastases":1,
"Pituitary":3,
"ANTIBODIES":1,
"METHODOLOGY":1,
"airway":1,
"anastomosis":1,
"cricoid":1,
"resection":1,
"trachea":1,
"BRAF fusions":1,
"NGS":1,
"Sptizoid melanoma":1,
"comprehensive genomic profiling":1,
"pancreatic acinar carcinoma":1,
"pilocytic astrocytoma":1,
"solid tumors":1,
"targeted therapy":3,
"Biliary tract":1,
"TTF-1":3,
"choledocho":1,
"Ferulic acid":1,
"TT cells":1,
"URG4/URGCP":1,
"gene expression testing":1,
"Bayesian model averaging":1,
"cancer risk estimation":1,
"dose-response model":1,
"radiation epidemiology":1,
"Angiogenesis":1,
"CXCR7":1,
"Chemokine receptor":1,
"Interleukin-8":1,
"Vascular endothelial growth factor":1,
"Collagen IV":1,
"Epidermal growth factor receptor":1,
"Quantum dot":1,
"Triple-negative breast cancer":1,
"neurocognitive dysfunction":1,
"pediatric cancer":1,
"proton therapy":1,
"radiation therapy":1,
"radiobiological risk estimates":1,
"ESCC":1,
"Kazakh":1,
"Malignant phenotype":1,
"PKM2":4,
"DTC":2,
"FDG":1,
"PET/CT":1,
"PET/MRI":1,
"follicular lesion of undetermined significance":1,
"follicular neoplasia":1,
"gene expression classifier":2,
"indeterminate cytology":1,
"Central neck dissection":1,
"diagnoses and examinations":1,
"gastric cancer":3,
"polymerase chain reaction":1,
"sentinel lymph node":1,
"Basement membrane":1,
"CAM":1,
"CEA":1,
"CSF":1,
"Carcinoembryonic antigen":1,
"Cell adhesion molecule":1,
"Cerebellum":1,
"Cerebrospinal fluid":1,
"DWI":1,
"Enterogenous cyst":1,
"FLAIR":1,
"Fluid-attenuated inversion recovery":1,
"GFAP":1,
"Glial fibrillary acidic protein":1,
"MRI":1,
"Magnetic resonance imaging":1,
"N-CAM":1,
"Neural cell adhesion molecule":1,
"PAS":1,
"Periodic acid-Schiff":1,
"Thyroid transcription factor-1":1,
"Bone geometry":1,
"Bone mineral density":1,
"CT":1,
"Fiberoptic endoscopy":1,
"Substernal":2,
"Analyses, DNA sequence":1,
"Anaplasia":1,
"BRAF mutation, human":1,
"endocrine disease":1,
"Hypopharynx":1,
"Larynx":2,
"CXCL16":1,
"macrophages":1,
"53BP1":1,
"DNA damage":1,
"DSB focus assay":1,
"absorbed dose to blood":1,
"biological dosimetry":1,
"dose response":1,
"γ-H2AX":1,
"acral melanoma":1,
"metachronous cancer":1,
"nonacral melanoma":1,
"other primary systemic cancer":1,
"prechronous or synchronous":1,
"Adenoma":1,
"Dwarfism":1,
"Rat":1,
"microcarcinoma":1,
"risk":3,
"thyroid-stimulating hormone":1,
"carcinoid":1,
"goblet cell":1,
"mucinous":1,
"ovary":2,
"struma ovarii":1,
"teratoma":2,
"Non-diagnostic cytology":1,
"OSNA":1,
"Pediatric carcinoma":1,
"Pediatric head and neck malignancies":1,
"Pediatric head and neck tumors":1,
"Pediatric malignancies":1,
"Pediatric sarcomas":1,
"Environmental exposure":1,
"Bone density":1,
"Thyrotropin":1,
"apoptosis signal-regulating kinase 1":1,
"orphan receptor 1":1,
"thyroid transcription factor 1":1,
"follicular carcinoma":1,
"Bethesda system":1,
"cytotechnologist performance":1,
"cytotechnologist-cytopathologist":1,
"interobserver agreement":1,
"galectin-3":1,
"papillary thyroid microcarcinoma":2,
"Bevacizumab":2,
"Conversion":1,
"Liver metastasis":2,
"Liver resection":1,
"Neoadjuvant chemotherapy":2,
"mFOLFOX6":1,
"Benign and malignant focal liver lesions":1,
"Hardness":1,
"Bexarotene":1,
"Bexaroteno":1,
"Cholesterol":1,
"Colesterol":1,
"Cutaneous T-cell lymphoma":1,
"Función tiroidea":1,
"Linfoma cutáneo de células T":1,
"Thyroid function":1,
"Discriminant analysis":1,
"Electrocardiogram":1,
"Short-term overt hypothyroidism":1,
"estrogen":1,
"tumor microenvironment":1,
"Adverse endocrine events":1,
"Brachytherapy":1,
"Head and neck":1,
"Paediatric oncology":1,
"Pituitary dysfunction":1,
"Radiotherapy":2,
"Rhabdomyosarcoma":1,
"Differentially expressed genes":1,
"ECM degradation":1,
"Enrichment analysis":1,
"RNA-sequencing":1,
"ST6GALNAC family":1,
"human follicular thyroid carcinoma cell line":1,
"invasive properties":1,
"miR-4299":1,
"tumorigenicity":1,
"CCDC67":1,
"molecular pathogenesis":1,
"prognostic marker":1,
"tumor suppressor":3,
"World Trade Center":1,
"cohort study":1,
"epidemiology":2,
"surveillance":2,
"BRAFV600E":1,
"cell signaling":1,
"drug resistance":1,
"vemurafenib":1,
"microRNA-let-7a":1,
"Circulating epithelial cells":2,
"Epithelial cell adhesion molecule":1,
"Prostate cancer":1,
"Ultrasound image":1,
"Wavelet transform":1,
"IR820":1,
"amino-glucose":1,
"heat shock protein 70":1,
"near infrared hyperthermia":1,
"tumor targeting":2,
"ABCG2":1,
"CD133":2,
"Cancer stem cells":1,
"Nestin":1,
"Protein Pathway Array":1,
"Signaling pathway":1,
"Anterior commissure of the larynx":1,
"Squamous-cell carcinoma":1,
"Supracricoid laryngectomy":1,
"Head and neck squamous cell carcinoma":2,
"clinical trials":1,
"drug therapy":1,
"lenvatinib":2,
"sorafenib":1,
"SIRT6":1,
"deacetylation":1,
"Metastatic":2,
"Primary":1,
"incidental":1,
"incidentaloma":1,
"nuclear medicine":1,
"BRAF V600E":1,
"activatable cell penetrating peptide":1,
"laryngoscopy":1,
"murine model":1,
"surgical molecular guidance":1,
"CD44":1,
"Medullary thyroid carcinoma (MTC)":1,
"cancer stem cells (CSCs)":1,
"lymphatic metastasis":2,
"time":1,
"ERBB2":1,
"MicroRNA-375":1,
"Cancer stem/progenitor cells":1,
"ER-α36":1,
"Epigallocatechin-3-gallate":1,
"Epithelial growth factor receptor":1,
"Curcumin":1,
"Human papillary thyroid carcinoma":1,
"Matrix metalloproteinases":1,
"TGF-β/Smad2/3":1,
"Accident nucléaire":1,
"Iode":1,
"Iodine":1,
"Nuclear power plant accident":1,
"Thyroïde":1,
"Leberfibrose":1,
"Mamma":1,
"Prostata":1,
"Schilddrüsenknoten":1,
"Ultraschall-Elastografie":1,
"acoustic radiation force impulse":1,
"breast imaging reporting and data system":1,
"cirrhose hépatique":1,
"elastographie échographique":1,
"fibrose":1,
"liver fibrosis":1,
"lélastographie statique":1,
"nodules de la thyroïde":1,
"prostate":1,
"shear wave elastography":1,
"strain elastography":1,
"transient elastography":1,
"ultrasound elastography":1,
"élastographie par onde de cisaillement":1,
"élastographie transitoire":1,
"Na+/I- symporter":1,
"Glu2–6-modified minigastrin":1,
"cholecystokinin subtype 2-receptor":1,
"kidney retention":1,
"minigastrin radioligand":1,
"neutral endopeptidase":1,
"phosphoramidon":1,
"749":1,
"gene expression":1,
"prognostic indicators":1,
"Clear-cell renal cell carcinoma":1,
"Functional variants":1,
"Liver cancer":1,
"Mutation pattern":1,
"Random forest":1,
"Autoimmunity":1,
"Autoimmunité":1,
"Hyperprolactinemia":1,
"Hyperprolactinémie":1,
"Maladies thyroïdiennes":1,
"Prolactin":1,
"Prolactine":1,
"Prolactinoma":2,
"Prolactinome":2,
"Thyroid diseases":1,
"myoferlin protein":1,
"non-small cell lung cancer":1,
"tissue array analysis":1,
"vascular endothelial growth factor receptor-2":1,
"carcinoma showing thymus-like differentiation of the thyroid":1,
"cluster of differentiation 117":1,
"cluster of differentiation 5":1,
"thymus-like":1,
"clinical characteristics":1,
"pathology":2,
"renal cell carcinoma":1,
"thyroid-like follicular carcinoma":1,
"Acromegaly":1,
"Hyperparathyroidism":1,
"Mutation and tumor":1,
"tyrosine kinse inhibitor":1,
"Fine-needle aspiration cytology":1,
"thyroid imaging reporting and data system":1,
"thyroid ultrasound":2,
"Renal cell carcinoma (RCC)":1,
"molecular genetics":1,
"renal tumor":1,
"Catalase":1,
"Glutathione":1,
"Total antioxidant capacity":1,
"CK19":1,
"CK7":1,
"TTF1":1,
"p63":1,
"Carcinoma":2,
"Infiltration":1,
"Thyroidectomy":5,
"Hurthle":1,
"Oncocytic":1,
"Oxyphilic":1,
"oncocytic changes":1,
"surgical treatment":1,
"Abducens palsy":1,
"clivus":1,
"ocular neuromyotonia":1,
"skull":1,
"FGF 23":1,
"Hypophosphatemia":1,
"Osteomalacia":1,
"Tumor induced osteomalacia":1,
"cancer mortality":1,
"hepatoma":1,
"pancreatic cancer":1,
"Gestational trophoblastic disease":1,
"Grossesse molaire":1,
"Hormone chorionique gonadotrophique":1,
"Human gonadotrophin chorinic":1,
"Hyperthyroidism":2,
"Hyperthyroïdie":1,
"Maladie gestationnelle trophoblastique":1,
"Molar pregnancy":1,
"Sialysation":1,
"Thyrotoxicose":1,
"Thyrotoxicosis":1,
"cisplatin":1,
"intra-arterial chemotherapy":1,
"neoadjuvant":1,
"capsular invasion":1,
"radioactive iodine ablation":1,
"Lymphoma":1,
"Multidetector computed tomography":1,
"CROHN'S DISEASE":1,
"IBD - GENETICS":1,
"INFLAMMATION":1,
"Multiple functions":1,
"NR4A":1,
"Novel ligands":1,
"Nuclear receptors":1,
"malignant":1,
"nodule":2,
"3&nbsp":1,
"T Magnetic Resonance Imaging":1,
"IDEAL sequences":1,
"Parathyroid adenoma":1,
"Presurgical localisation":1,
"Anabolic hormones":1,
"Hormones anabolisantes":1,
"Thyroid volume":1,
"Volume thyroïdien":1,
"Clinicopathology":1,
"MicroRNA-200":1,
"Real-time quantitative PCR":1,
"18F-FDG PET/CT":1,
"High/intermediate-risk thyroid carcinoma":1,
"Therapeutic management":1,
"ACTH = adrenocorticotropic hormone":1,
"FSH = follicle-stimulating hormone":1,
"GH = growth hormone":1,
"GnRH = gonadotropin-releasing hormone":1,
"IGF-1= insulin-like growth factor-1":1,
"LH = luteinizing hormone":1,
"NFA = nonfunctional adenoma":1,
"T4 = thyroxine":1,
"TRH = thyrotropin-releasing hormone":1,
"TSH = thyroid-stimulating hormone":1,
"endocrine deficits":1,
"hypopituitarism":1,
"nonfunctional adenoma":1,
"pituitary surgery":1,
"Biopsy":2,
"Population-based cohort":1,
"Thyroid ablation":1,
"rhTSH":1,
"18F-FDG-PET/CT":1,
"paraneoplastic cerebellar degeneration":1,
"paraneoplastic neurological syndrome (PNS)":1,
"Carcinoma del quiste":1,
"Cyst carcinoma":1,
"Quiste tirogloso":1,
"Sistrunk":1,
"Thyroglossal cyst":1,
"Tiroidectomía":1,
"NF-κB":1,
"PTC":1,
"Twist1":1,
"Differential diagnosis":1,
"Neck mass":1,
"Spindle epithelial tumor with thymus-like differentiation (SETTLE)":1,
"Therapy":1,
"Tumor of the thyroid gland":1,
"Hypocalcemia":1,
"Parathyroid glands":1,
"cutaneous metastases":1,
"spindle cells":1,
"RET- PTC":1,
"TERT":1,
"pediatric thyroid carcinoma":1,
"ETV6/NTRK3":1,
"gene fusions":1,
"molecular diagnostics":1,
"molecular pathology":1,
"pediatric":2,
"demographic":1,
"endocrine cancer":1,
"parathyroid cancer":1,
"patient community":1,
"patient environment":1,
"surgeon volume":1,
"fetal development":1,
"mothers":1,
"risk factors":2,
"lymph nodes":2,
"predictive model":1,
"Ephrin receptor":1,
"genome-wide":1,
"oncogenic gene signature":1,
"tumor progression":1,
"SSc":1,
"thyroid autoimmunity":1,
"Cell proliferation":1,
"Polycomb enhancer of zeste homolog 2 (EZH2)":1,
"Thyroid-stimulating hormone receptor (TSHR)":1,
"lncRNA PVT1":1,
"Metastatic lung carcinoma":1,
"Napsin A":1,
"Primary lung carcinoma":1,
"gender":1,
"radiation exposure":1,
"well-differentiated thyroid cancer":1,
"p16":1,
"p27":1,
"p53":1,
"Ribonucleotide reductase large subunit M1":1,
"Undifferentiated thyroid carcinoma":2,
"Langerhans cells":1,
"cutaneous metastasis":2,
"oncology":1,
"Asistencia sanitaria integral":1,
"Comprehensive health care":1,
"Consenso":1,
"Consensus":1,
"Cáncer de tiroides":1,
"Equipo multidisciplinar":1,
"Flujo de pacientes":1,
"Multidisciplinary team":1,
"Organización":1,
"Organization":1,
"Patient flow":1,
"Requirements":1,
"Requisitos":1,
"Plasma":1,
"miR-940":1,
"Bethesda":1,
"atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS)":1,
"fine-needle aspiration (FNA)":1,
"follicular variant":2,
"noninvasive":1,
"noninvasive follicular thyroid (NIFT)":1,
"AKT3":1,
"miR-29a":1,
"Pancreatic ductal adenocarcinoma":1,
"Warburg effect":1,
"Children":1,
"(131)I":1,
"Cáncer diferenciado de tiroides":1,
"Dosimetría individualizada":1,
"Individualised dosimetry":1,
"Metabolic therapy":1,
"Terapia metabólica":1,
"Mesenchymal neoplasm":1,
"Schwannoma":1,
"Graves' disease":1,
"LKB1":1,
"STK11":1,
"Adrenal metastasis":1,
"Pancreatic metastasis":1,
"Renal metastasis":1,
"median household income":1,
"socioeconomic status":1,
"well differentiated thyroid cancer":1,
"Telomerase":1,
"Thyroid cancer, papillary":3,
"lymph node washout":1,
"PARP4":1,
"breast":1,
"locally advanced":1,
"nonsmall cell lung cancer":1,
"Three-dimensional ultrasonography":1,
"Tomographic ultrasound imaging":1,
"Tumor staging":1,
"Lymphadenectomy":1,
"Subtotal/total thyroidectomy":1,
"Bcl-xL":1,
"TRAIL":1,
"TRAIL-resistant":1,
"Valproic acid":1,
"BRAF V600E mutation":1,
"TERT promoter mutation":1,
"genetic molecular markers":1,
"telomerase reverse transcriptase":1,
"Myotonic dystrophy type 1":1,
"Tumor":1,
"Pendred syndrome":1,
"cervical lymph node":1,
"conventional smear":1,
"liquid-based cytology":1,
"Thyroid cancer, follicular":1,
"follow-up studies":1,
"questionnaires":1,
"retinoblastoma":1,
"survivors":1,
"early detection of cancer":1,
"radioactive hazard release":1,
"BAP1":1,
"Cancer genetics":1,
"tumor predisposition syndrome":1,
"Childhood cancer survivors":1,
"Donor site":1,
"Immediate reconstruction":1,
"Nipple-sparing mastectomy":1,
"Perforator flap":1,
"Skin-sparing mastectomy":1,
"negative predictive value":1,
"procalcitonin":1,
"Anthropometry":1,
"Cosmesis":1,
"Endocrine surgery":1,
"Follow-up":1,
"Outcomes":1,
"Robotic":1,
"Scar":1,
"Transaxillary":1,
"MAPK genetic alterations":1,
"Sonic Hedgehog pathway":1,
"type 3 deiodinase, papillary thyroid carcinoma":1,
"Ascorbic acid (PubChem CID: 54670067)":1,
"Formulation":1,
"Freeze-Drying":1,
"Gentisic acid (PubChem CID: 3469)":1,
"In-111":1,
"Minigastrin":1,
"Radiopharmaceutical Kit":1,
"Sodium hydroxide (PubChem CID: 14798)":1,
"l-Methionine (PubChem CID: 6137)":1,
"Ciliated muconodular papillary tumor":1,
"Glandular papilloma":1,
"Mucinous adenocarcinoma":1,
"Papillary adenocarcinoma":1,
"Peripheral lung tumor":1,
"Ectopic":1,
"Intrathyroidal":1,
"Thymoma":1,
"Thymus":1,
"thyroid atypia of undetermined significance":1,
"thyroid fine-needle aspiration biopsy":1,
"thyroid follicular lesion of undetermined significance":1,
"Mitochondria":1,
"Sellar neoplasms":1,
"Spindle cell oncocytoma":1,
"In situ hybridization":1,
"MicroRNA":1,
"Non-coding RNA":1,
"lncRNA":1,
"Regional":1,
"Data Reporting":1,
"Patient-reported outcome":1,
"Quality of Life [I01 800]":1,
"PI-3 kinase":1,
"c-Met":1,
"cell motility and invasion":1,
"sonic hedgehog signaling pathway":1,
"Alu repeats":1,
"DNA hypomethylation":1,
"human cancer":1,
"routine clinical biospecimens":1,
"NF1":1,
"TSC1":1,
"everolimus":1,
"mTOR":1,
"next-generation sequencing":1,
"AKT pathway":1,
"miR-451a":1,
"Immune-checkpoint inhibitors":1,
"Immune-related adverse events":1,
"Ipilimumab":1,
"Nivolumab":1,
"Pembrolizumab":1,
"Renal cancer":1,
"Nonalcoholic fatty liver disease":1,
"Type 2 diabetes":1,
"frequency":1,
"IGF-1R":1,
"miR-30a":1,
"p53R273H":1,
"ROI":1,
"Young modulus":1,
"elasticity imaging techniques":1,
"follicular thyroid neoplasm":1,
"reliability":1,
"reproducibility":1,
"shear-wave elastography":1,
"SEER":1,
"age":1,
"nomogram":1,
"CCK2R":1,
"CCKBR":1,
"cholecystokinin 2 receptor":1,
"gastrin receptor":1,
"WNT signaling":1,
"Gerotarget":1,
"elderly patients":1,
"liquid based cytology":1,
"malignancies":1,
"CUDC-101":1,
"carfilzomib":1,
"combination therapy":1,
"adrenal-associated endocrinopathy":1,
"adrenocortical neoplasm":1,
"aging":1,
"and thyroid":1,
"cysts":1,
"diabetes mellitus":1,
"endocrine tumors":1,
"endocrinopathies":1,
"estrogen-induced anemia":1,
"ferret":1,
"gonadectomy":1,
"insulinoma":1,
"islet cell tumor":1,
"pancreatic polypeptidoma":1,
"testis":1,
"18F-fluorodeoxyglucose":1,
"Positron-emission tomography":1,
"BRAF inhibitor":1,
"MEK inhibitor":1,
"programmed cell death-1":1,
"programmed cell death-ligand 1":1,
"First-degree family history":1,
"Bone metastasis":1,
"Bone scintigraphy":1,
"F-18 sodium fluoride":1,
"Fish consumption":1,
"Lake Ontario":1,
"Omega-3 fatty acids":1,
"Polychlorinated biphenyls":1,
"GWAS":1,
"Inbreeding":1,
"Runs of homozygosity":1,
"I-131":1,
"irradiation":1,
"radiopharmaceuticals":1,
"herpesviruses":1,
"polyomaviruses":1,
"HMGA1":1,
"RNA interference":1,
"S100A13":1,
"Adjuvant":1,
"Aromatase inhibitors":1,
"Early breast cancer":1,
"Functional Assessment of Cancer Therapy-Breast":1,
"Hormone receptor-positive early-stage breast cancer postmenopause":1,
"Prospective":1,
"Quality of life":1,
"Trial outcome index":1,
"Bronchopneumonia":1,
"enteritis":1,
"gazelle":1,
"mortality":1,
"trauma":1,
"malignant potential":1,
"tumors":1,
"atherosclerosis":1,
"genome‐wide association study":1,
"non‐coding RNA":1,
"stroke":1,
"Breast neoplasms":1,
"Cancer screening":1,
"Chronic disease":1,
"Comorbidity":1,
"France":1,
"Uterine cervical neoplasms":1,
"Oncogenic signaling pathway":1,
"Pin1":1,
"Treatment":1,
"Ectopic thyroid cancer":1,
"Local invasion":1,
"Stent":1,
"Trachea relapse":1,
"multiple kinase inhibitor":1,
"progression-free survival":1,
"Notch 1 receptor":1,
"radioiodine remnant ablation":2,
"tumor aggressiveness":1,
"solitary pulmonary metastasis":1,
"surgical resection":1,
"Breast metastasis":1,
"Isolated metastasis":1,
"Low-risk thyroid carcinoma":1,
"Neck ultrasound":1,
"Thyroglobulin temporal trend":1,
"Thyroid adenoma":1,
"neoplasm of the endocrine system":1,
"Laryngocele":1,
"laryngeal cyst":1,
"fluorine-18-fluorodeoxyglucose":1,
"retropharyngeal":1,
"Nodular Goiter":1,
"medullary carcinoma of thyroid gland":1,
"the same side":1,
"thyroid papillary carcinoma":1,
"cutaneous":1,
"lung":1,
"bone":1,
"laryngeal spasm":1,
"low calcium":1,
"thyroid cancer surgery":1,
"Cytomorphology":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2016年第1季度论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
